Celera Genomics celera.com


Public list: Pharma Startups (4740) Cancer Therapeutics (1146)

Celera Genomics is one of three business segments of Applera Corporation. Celera Genomic's mission is to discover and develop meaningful new therapies that improve human health. We are applying our diverse genomics, bioinformatics, proteomics, medicinal chemistry and biology technology platforms to identify and validate drug targets, and to discover novel therapeutics. Celera Genomics currently has a portfolio of programs based primarily on protease inhibitors for three major therapeutic areas: ...Show all

Celera Genomics is one of three business segments of Applera Corporation. Celera Genomic's mission is to discover and develop meaningful new therapies that improve human health. We are applying our diverse genomics, bioinformatics, proteomics, medici...Show all

Company (Acquired)

Phone:

Fax:

45 West Gude Drive

Rockville, 20850
Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Celera Genomics $0M May 17, 2011
See all 54 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Celera Genomics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Xanthus Pharmaceuticals

Cambridge, Massachusetts, United States
AcquiredXanthus Pharmaceuticals, Inc. is developing a portfolio of novel, clinical-stage, small-molecule therapeutic candidates through a management team whose accomplished track record encompasses all aspects of drug development, from discovery through regulatory approval and commercialisation. The Company is applying its expertise to advance its current pipeline to address significant unmet medical need in oncology and autoimmune diseases. Xanthus is headquartered in Cambridge, Massachusetts with an a...Show allLogin to see details

Allon Therapeutics

Vancouver, British Columbia, Canada
AcquiredAllon Therapeutics Inc. is a clinical-stage biotechnology company developing treatments for major neurodegenerative conditions. Allon has 3 Phase II human efficacy trials underway pursuing three large underserved markets: Alzheimer's disease, schizophrenia and cognitive impairment.The Company is listed on the Toronto Stock Exchange under the trading symbol "NPC" (Neuroprotection CompanyTM) and based in Vancouver.Login to see details
See all 54 competitors